// App-Quantinova.ai

667 : Substantially Improved Outcome of Adult Burkitt Non-Hodgkin Lymphoma and Leukemia Patients with Rituximab and a Short-Intensive Chemotherapy; Report of a Large Prospective Multicenter Trial

Researchers

Presenter

  • Jan Walewski

Principal Investigators

  • Michael Kneba

  • Markus Schuler

  • Ingo Schmidt-Wolf

  • Joachim Beck

  • Bernd Hertenstein

  • Albrecht Reichle

  • Katarzyna Domanska-Czyz

  • Rainer Fietkau

  • Heinz-August Horst

  • Harald Rieder

  • Mathias Schmid

  • Stefan Schwartz

  • Thomas Burmeister

  • Nicola Goekbuget

  • Wolfgang Hiddemann

  • Anja Baumann

  • Hubert Serve

  • Ulrich Duhrsen

  • Andreas Huttmann

  • Eckhard Thiel

  • Jolanta Dengler

Medical Centers

  • Hematology and Oncology, Charite Campus Benjamin Franklin, Berlin, Germany

  • Center for Integrated Oncology CIO, University of Bonn, Bonn, Germany

  • Hamatologie und Onkologie, Klinikum Bremen Mitte, Bremen, Germany,

  • Hematology, University Hospital, Essen, Germany

  • Department of Lymphoid Diseases, The Maria Sklodowska-Curie Memorial Institute and Centre of Oncology, Warsaw, Poland

  • University of Kiel, Kiel, Germany

  • Hematology and Oncology, University Regensburg, Regensburg, Germany

  • Medical Dept. 1, University Hospital Dresden, TU Dresden, Dresden, Germany

  • University of Ulm, Ulm, Germany

  • Dept. of Medicine III, University Hospital, Mainz, Germany

  • Hematology and Oncology, Charite University Hospital Berlin, Berlin, Germany

  • Abteilung Innere Medizin V, Universitaetsklinikum, Heidelberg, Germany

  • Internal Medicine , University of Erlangen, Erlangen, Germany

  • Department of Hematology and Oncology, University Hospital, Rostock, Germany

  • University Hospital Grosshadern, Munich, Germany

  • Internal Medicine III, University of Ulm, Ulm, Germany

  • Department of Hematology and Medical Oncology, Charite, CBF, Berlin, Germany

  • Department of Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt Am Main, Germany

  • Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany

  • Department of Internal Medicine II, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany

Locations

  • Poland

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Mediastinal mass

  • Hodgkin's Lymphoma

  • Burkitt lymphoma

  • Neutropenia

  • Mucositis

  • Lymphomas

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Cytarabine liposomal

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Methotrexate

  • Etoposide

  • Etoposide phosphate

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved